SCHEMBL6652096

SCHEMBL6652096

O=C(Cl)c1ccc2cc(OCc3ccccc3)ccc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.63
NR4A2 P43354 2/20 0.59
MRGPRX4 Q96LA9 1/20 0.59
NR4A1 P22736 1/20 0.59
NR4A3 Q92570 1/20 0.59
NPC1 O15118 1/20 0.58
MAPT P10636 1/20 0.58
P2RY14 Q15391 1/20 0.56
MAOB P27338 3/20 0.56
PARP10 Q53GL7 1/20 0.56
SRD5A2 P31213 4/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
PLA2G4B P0C869 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5921632 0.88 MRGPRX4 (0.76) ALOX5NR4A2MRGPRX4NR4A1NR4A3
Hydrochloric Acid SCHEMBL8380168 0.86 MRGPRX4 (0.74) ALOX5NR4A2MRGPRX4NR4A1NR4A3
SCHEMBL228290 0.85 NR4A2 (0.74) ALOX5NR4A2NR4A1NR4A3NPC1
SCHEMBL4258805 0.85 MRGPRX4 (0.76) ALOX5NR4A2MRGPRX4NR4A1NR4A3
SCHEMBL340107 0.84 NR4A2 (0.77) NR4A2MRGPRX4MAOBSRD5A2MEN1
SCHEMBL30412560 0.84 NR4A2 (0.77) NR4A2MRGPRX4MAOBSRD5A2MEN1
SCHEMBL3235219 0.84 ALOX5 (0.61) ALOX5NR4A2MRGPRX4NR4A1NR4A3
SCHEMBL10839211 0.82 SMPD1 (0.74) ALOX5MRGPRX4NPC1MAPT
SCHEMBL1779167 0.82 ALOX5 (0.59) ALOX5NR4A2MRGPRX4NR4A1NR4A3
SCHEMBL8378881 0.81 NR4A2 (0.68) ALOX5NR4A2NR4A1NR4A3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5246953-A None JP disclosed
CN-103627407-B Cholesteric liquid crystal display 2,2 '-binaphthalene ester chiral dopant 肯特显示器公司 2016-12-28 CN disclosed
CN-103339224-B Tetraoxybiphenyl ester chiral dopant for cholesteric liquid crystal displays KENT DISPLAYS INC 2015-07-22 CN disclosed
US-9005478-B2 2,2′-binaphthalene ester chiral dopants for cholesteric liquid crystal displays KENT DISPLAYS INCORPORATED (US) 2015-04-14 US disclosed
US-20140117284-A1 2,2'-Binaphthalene Ester Chiral Dopants for Cholesteric Liquid Crystal Displays KENT STATE UNIVERSITY (US) 2014-05-01 US disclosed
US-8709281-B2 2,2′-binaphthalene ester chiral dopants for cholesteric liquid crystal displays KENT STATE UNIVERSITY (US) 2014-04-29 US disclosed
CN-103627407-A 2,2'-Binaphthalene Ester Chiral Dopants for Cholesteric Liquid Crystal Displays UNIV KENT STATE OHIO 2014-03-12 CN disclosed
US-20140054498-A1 2,2'-Binaphthalene Ester Chiral Dopants for Cholesteric Liquid Crystal Displays KENT STATE UNIVERSITY (US) 2014-02-27 US disclosed
CN-103339224-A Tetraoxybiphenyl ester chiral dopant for cholesteric liquid crystal displays KENT DISPLAYS INC 2013-10-02 CN disclosed
US-20120273725-A1 Tetraoxybiphenyl Ester Chiral Dopants for Cholesteric Liquid Crystal Displays KENT STATE UNIVERSITY (US) 2012-11-01 US disclosed
US-5891359-A FLUOROTRIESTERAROMATIC COMPOUND FOR LIQUID CRYSTALS SHOWA SHELL SEKIYU KABUSHIKI KAISHA (JP) 1999-04-06 US disclosed
US-5861108-A IMPROVES HIGH SPEED RESPONSE PROPERTY AND TEMPERATURE DEPENDENCY OF THE RESPONSE TIME MITSUI CHEMICALS, INC. (JP) 1999-01-19 US disclosed
EP-0757032-A2 Naphthalene compound, and liquid crystal composition and liquid crystal element using the same MITSUI TOATSU CHEMICALS, INC. (JP) 1997-02-05 EP disclosed
US-5451339-A Liquid crystal monomeric compound and liquid crystal polymer compound modified therewith SHOWA SHELL SEKIYU KABUSHIKI KAISHA (JP) 1995-09-19 US disclosed
US-5443755-A Optically active tetrahydropyrane derivatives, liquid crystal composition and liquid crystal device containing the same KASHIMA OIL COMPANY (JP) 1995-08-22 US disclosed
US-5364561-A Diluent; optically tristable; electrooptics SHOWA SHELL SEKIYU KABUSHIKI KAISHA (JP) 1994-11-15 US disclosed
US-5310500-A Fluorinated naphthalenecarboxylic acid ester derivatives; electrooptics SHOWA SHELL SEKIYU KABUSHIKI KAISHA (JP) 1994-05-10 US disclosed
EP-0571276-A1 Liquid crystal monomeric compound and liquid crystal polymer compound modified therewith Showa Shell Sekiyu Kabushiki Kaisha (JP) 1993-11-24 EP disclosed
JP-H05246953-A LIQUID CRYSTAL COMPOUND SHOWA SHELL SEKIYU KK 1993-09-24 JP disclosed
EP-0518636-A1 Liquid crystal compounds and compositions SANYO CHEMICAL INDUSTRIES LTD. (JP) 1992-12-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140054498-A1 2,2'-Binaphthalene Ester Chiral Dopants for Cholesteric Liquid Crystal Displays DHCR7, NR1H4, CYP46A1 ALOX5 1166/4885NR4A2 125/4885MRGPRX4 3934/4885
US-20120273725-A1 Tetraoxybiphenyl Ester Chiral Dopants for Cholesteric Liquid Crystal Displays DHCR7, CYP7A1, CCR7 ALOX5 1057/4885NR4A2 110/4885MRGPRX4 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.